Search

Nanoemulgel (NEG) pharmaceutical formulations are gaining popularity because of their ability to serve both as a nanoemulsion and as a gel. These products are well-known for their ease of use, spreadability, controlled release, and ability to hydrate dry skin. Natural essential oils have been shown to promote the cutaneous permeability of topical formulations, enhancing medication safety and efficacy. Herein, we developed NEG for the enhanced permeation of posaconazole against candidiasis using Mustard oil (Mustard oil-NEG), using the gelling agents carbopol 943 and hydroxypropyl methylcellulose (HPMC). We tested various excipients to increase the solubility of posaconazole and formulate a nanoemulsion (NE). We measured the NE droplet particle size, shape, entrapment efficiency, and drug release. Furthermore, the physicochemical properties of the optimized nanoemulsion formulation were characterized by techniques such as Fourier transform infrared (FT-IR) spectroscopy and X-ray diffraction (XRD) analysis. The NEs were loaded into gels to form NEGs. NEGs were characterized for drug content, homogeneity, rheology, spreadability, and antifungal activity against Candida albicans, both in vitro and in vivo. Optimized posaconazole NEG preparations consisted of either 15% Mustard oil or 20% Arachis oil. Droplet sizes in the optimized NEs were <100 nm, and the polydispersity indexes were 0.24 and 0.26. The percentages of posaconazole released after 24 h from the clove-oil-NEG and eucalyptus-oil-NEGs were 91 ± 4.5 and 89 ± 7%, respectively. Scanning electron microscopy (SEM) showed that the NEGs had a smooth, uniform, and consistent shape and internal structural organization. The drug contents in the clove-oil-NEG and eucalyptus-oil-NEG were 98.5 ± 2.2 and 98.8 ± 3.4%, respectively. Permeation values of posaconazole from clove-oil-NEG and eucalyptus-oil-NEG were 117 ± 7 and 108.34 ± 6 µg cm-2, respectively. The posaconazole NEG formulations also had higher levels of fungal growth inhibition than a marketed formulation. Finally, in vivo studies showed that the NEGs do not irritate the skin. Posaconazole NEG with either 15% Mustard oil or 20% Arachis oil is stable with better efficacy than posaconazole alone due to excellent dispersion, drug dissolution, and permeability and thus might be recommended for the effective and safe treatment of candidiasis. [ABSTRACT FROM AUTHOR]

Researchers wanted to develop skin liposomal formulations that would carry 5-fluorouracil to the cancer site in an adjuvant way, as well as enhancing the health of basal cell carcinoma patients who were experiencing unfavorable consequences. Using Strat-M films in vitro, the detailed skin-damaging potential of the synthesized skin liposomes and the sensitivity to 5-fluorouracil were evaluated. It was found that the Korsmeyer-Pepas condition was the best one for controlling drug administration. Additionally, it is unknown if it might irritate skin. The vitality and hemolytic potential of the cytostatic effect on the recommended anti-tumor therapy were also examined in in vitro investigations. Our findings suggest that a sodium alginate and hyaluronic acid crosslinked gel containing AS1411 aptamer liposomes coated with 5-fluorouracil is the optimal liposome solution. This liposome characterization appears to have good biological safety implications and may be exploited as a different approach to basal cell carcinoma skin treatments. [ABSTRACT FROM AUTHOR]

The limited water solubility and dissolution of drugs classified under the Biopharmaceutics Classification System (BCS) class II category provide constraints on their oral bioavailability. In the present study, a self-micro emulsifying drug delivery system (SMEDDS) was employed to enhance the aqueous solubility and oral bioavailability of toremifene, which belongs to the Biopharmaceutics Classification System (BCS) class II category. The selection of Oleic Acid, Transcutol-P, and Span 20 as the oil, surfactant combination, and cosurfactant, respectively, was based on the solubility. The optimal composition (Oleic Acid / Transcutol-P / Span 20 in a volume ratio) for toremifene, which exhibits a small droplet size (132.1 nm) and consistent microemulsification was determined by the use of pseudo-ternary phase diagrams. Differential scanning calorimetry and powder X-ray diffraction were employed to identify the loss of crystallinity in lyophilized toremifene. The results indicated that toremifene existed in a molecularly dissolved or amorphous state inside the SMEDDS formulation. The saturation solubility and dissolving rate of toremifene -SMEDDS exhibited significant enhancements compared to toremifene powder when tested in water, simulated gastric fluid (pH 1.2), and simulated intestinal fluid (pH 6.8). The female rats exhibited a 1.94-fold increase in the area under the curve and a 1.80-fold increase in the highest plasma concentration following the oral administration of toremifene-SMEDDS compared to the oral administration of the toremifene dispersion. In summary, the findings of our study suggest that self-microemulsifying drug delivery systems (SMEDDS) have promise as an oral formulation for enhancing the therapeutic efficacy of toremifene. [ABSTRACT FROM AUTHOR]

In this study, silver nanoparticles (AgNPs) were made quickly and safely without the use of harmful chemicals by combining silver nitrate in aqueous solution with Mulberry leaf extract. The extract from mulberry leaves works as a stabilising and reducing agent. A peak maximum is visible in the UV-Vis spectroscopy at 430 nm. The roughly sphericalshaped synthetic AgNPs seen in the transmission electron microscopy (TEM) image have a size range of 15 to 20 nm. The average particle size is assessed to be 10 nm in the TEM picture of the Nano Silver solution sample produced by the microwave aided approach. A distinct absorption band about 415 nm is visible in the UV-vis spectra of silver nanoparticles made with microwave assistance (AgNPs mw). Silver nanoparticle peak variations in the UV-Vis spectrum of AgNPsmw after two months of storage are minimal. [ABSTRACT FROM AUTHOR]

Menstruation stops permanently for at least a year at menopause, a common, non-pathologic illness. All menstrual females experience menopause as a result of non-pathologic oestrogen insufficiency. 51 is the average age for menopause. The majority of women suffer vasomotor symptoms, although menopause can also have an impact on the urogenital and cardiovascular systems, among other things. In this exercise, the presentation, assessment, and management of menopause are reviewed, and the importance of an interdisciplinary team approach to patient care is emphasized. 51 is the average age for menopause. The majority of women suffer vasomotor symptoms, but menopause also has an impact on the urogenital, cardiovascular, and psychogenic systems of the body. 51 is the average age for menopause. Most women have vasomotor symptoms, but there are numerous other effects of menopause. Menopause typically occurs at age 51. The majority of women suffer vasomotor symptoms, but menopause also has an impact on the urogenital, cardiovascular, and psychogenic systems of the body. Hot flashes, sweating, sleep issues, mental disturbances, and monthly irregularities are among the early menopausal symptoms linked to the increasing decreases in hormone secretion and ovarian oestrogen insufficiency described in the literature. Vasomotor symptoms are experienced by 75% of women throughout menopause. Most women have VMS at some point throughout the menopausal transition. VMS (hot flushes or night sweats) are the most commonly reported of the basic symptoms that make up the menopause. 60-80% of women reported VMS throughout the menopausal transition in the Study of Women's Health across the Nation (SWAN), one of the largest studies on menopausal women. Medical intervention is not necessary for menopausal illness. Instead, treatments concentrate on controlling or avoiding chronic illnesses that may develop with ageing as well as curing your indications and symptoms. Hormone replacement therapy (HRT), an effective allopathic treatment for menopausal syndrome, may also cause vasoregulatory dysfunction, elevated blood pressure, and venous thrombosis. Additionally, the risk of developing cancer in vitally important functional organs like the cervix, endometrium, ovaries, and breast rises. [ABSTRACT FROM AUTHOR]

Polycystic ovarian syndrome (PCOS) is the most frequent endocrinopathy in women of reproductive age, characterized by hyperandrogenism and chronic oligo/ anovulation. PCOS is a complex illness that is impacted and complicated by a variety of genetic and environmental factors. The disruption of reproductive hormones such as LH, FSH, oestrogen, and testosterone disrupts the normal menstrual cycle and can result in oligomenorrhoea and amenorrhea-like abnormalities. Although there are significant variations between people, PCOS is characterized by hyperandrogenism, irregular menstruation, and different sized ovarian cysts. Polycystic ovarian syndrome (PCOS) is the most frequent endocrinopathy in women of reproductive age, characterized by hyperandrogenism and chronic oligo/ anovulation. PCOS is a complex illness that is impacted and complicated by a variety of genetic and environmental factors. Additionally, these women most likely have a higher risk of ovarian cancer, venous thromboembolism, cardiovascular and cerebrovascular events, and other illnesses. In addition to its enormous economic burden (an annual health-care expenditure of $5.39 billion in the United States in 2019), PCOS has a negative impact on the long-term health of affected women. The most prevalent endocrine condition, known as polycystic ovary syndrome (PCOS), affects 6%–8% of women globally who are of reproductive age. The first studies to ascertain prevalence in a medically unselected (unbiased) population were started by Azziz and colleagues, who reported PCOS prevalence’s ranging from 4% to 6.6% among unselected reproductive-age women living in the Southeast of the United States using the NIH 1990 criteria. The demand for herbal medications has developed as a result of high economic costs and a large number of unfavourable side effects linked with the use of allopathic drugs. Herbal plants have been a key source of therapeutic remedies since ancient times. Exceptionally, despite the huge transformation in the pharmaceutical area, the use of herbal treatments is expanding day by day in underdeveloped countries. [ABSTRACT FROM AUTHOR]

Present is a low-cost and environmentally beneficial approach for producing silver nanoparticles from discarded pineapple leaves utilising microwave-assisted extraction. AgNPs are produced environmentally friendly using a straightforward reduction technique and silver nitrate. The ideal conditions for green synthesis are determined by taking into account a number of factors, such as the silver nitrate concentration (5–25 mM), the incubation period (2–24 h), and the sample volume (2–8 mL). The reduction of silver metal ions into silver nanoparticles is indicated by the appearance of an absorption band in the UV-Vis spectro-photometer between 400 and 500 nm. Longer run times, higher silver nitrate solution concentrations, and larger sample volumes are all observed to improve absorption intensity. The green synthesised silver nanoparticles range in size from 40 to 150 nm and exhibit hexagonal spherical shapes, according to FE-SEM studies. Furthermore, the presence of green synthesised AgNPs is confirmed by FTIR and XRD studies. In comparison to non-microwave-assisted treatment, silver nanoparticles treated with a microwave show increased antibacterial activity against Escherichia coli, Bacillus subtilis, and Staphylococcus aureus. Silver nanoparticles must be present at a minimum of 60 g/mL to suppress bacterial growth. Overall, this study provides an avenue with substantial potential for the environmentally friendly and economically advantageous green synthesis of silver nanoparticles employing the microwave-assisted technique [ABSTRACT FROM AUTHOR]

In order to achieve increased felodipine delivery via transdermal delivery, the study investigated the parameters for improving various membrane combinations that incorporate lecithin derived from soy and eggs, in addition to an edge activator. This was done in order to achieve increased transdermal delivery. The Components and the Processes An approach known as rotational evaporation sonication was used in order to bring about the creation of a tranfersomal formulation. All of the following aspects of the formulation were evaluated and analysed: the polydispersity index, also known as the PDI, the zeta potential, the efficacy of trapping and loading, the deformability index, and in vitro skin penetration. Results: It was discovered that the best formulation would consist of spherical nanovesicles with a size of 75.71 5.4 nm, a PDI of 0.228, and a zeta potential of 49.8. (MF8). The fact that MF8's deformability index is so high—119.68—suggests that it attained the maximum degree of loading efficiency and entrapment possible. As compared to the transdermal control formulation, MF8's in vitro permeation through rat skin showed a 256% increase in permeability (flux = 23.72 0.64), with zero-order kinetics. This was in contrast to the transdermal control formulation, which improved permeability.This was determined by comparing the results to the transdermal control formulation (Case-II). Studies on the pharmacokinetics of the drug indicated that when transdermal therapy was compared to oral administration, the transdermal treatment resulted in a generally stable and maintained blood concentration with low plasma change, as well as a rapid and prolonged peak duration. The findings of confocal laser scanning microscopic studies, which showed that the medication quickly penetrated through dermal layers, were compatible with the relative bioavailability of felodipine, which was found to be 358.42% compared to oral administration. The results demonstrate that felodipine-loaded transfersomes are transcendent because they show that modifying the composition and manufacturing process had a significant influence on the features of the vesicles. [ABSTRACT FROM AUTHOR]

Alpinia calcarata rhizome ethanolic extract was tested for anti-asthmatic, antioxidant, and anti-inflammatory properties. Adaptogens normalize leukocytosis after milk consumption. Eosinophils are necessary for allergic illness development. The plant extract significantly reduced allergic asthmarelated eosinophil cell count compared to the control group. Eosinophil count decreases cell recruitment and IL-4, IL-5, and IL-13, which affect cell count. Studies on milk-induced leukocytosis and eosinophils verified the plant extract's anti-asthmatic capabilities. In guinea pigs, goats, horses, dogs, and humans, histamine contracts trachea and bronchial muscles. Tracheas in guinea pigs test asthma drugs. The isolated guinea pig trachea contracts dosedependently after H1 receptor stimulation. Alpinia calcarata reduced histamine-induced trachea constriction in solitary guinea pigs, proving its anti-asthmatic and H1 receptor antagonist capabilities. Hydrogen peroxide scavenging and reduction were used to test antioxidants. A hydrogen peroxide-scavenging Alpinia calcarata rhizome ethanol extract. Hydrogen peroxide scavenged less than ascorbic acid. Increasing Alpinia calcarata rhizome ethanolic extract dramatically lowered power. In vitro, ethanolic Alpinia calcarata rhizome extract stabilized rabbit red blood cell membranes and prevented protein denaturation. The ethanolic Alpinia calcarata rhizome extract was anti-asthmatic. Antioxidant and anti-inflammatory characteristics aid the plant's anti-astatic effects. Most asthma medications are steroidal. The phytochemical study identified steroids and flavonoids. Chemical moieties may make the plant anti-asthmatic. The findings support the conventional and advise more anti-asthmatic active component study. [ABSTRACT FROM AUTHOR]

Background: Urolithiasis is a medical condition that, despite substantial research in the field of urology, has yet to find a cure within the allopathic medical approach. The process of stone development, known as nephrolithiasis, can occur within the kidney or any segment of the urinary tract, encompassing the ureters and bladder. Material and Methods: The seeds of Cassia auriculata (Linn.) were obtained in June 2021 from Mettukadai hamlet, located in the Erode District of Tamilnadu, India. The herbarium of the plant was meticulously assembled, verified, and afterwards deposited as a voucher specimen. The voucher specimen was retained within the college premises for future reference. Results: The current investigation involved conducting a preliminary phytochemical analysis on the ethanolic seed extract of Cassia auriculata Linn. The research revealed the existence of many phytochemical constituents, including Alkaloids, Flavanoids, Carbohydrate, Sterols, Phytosterols, Phenols, Terpenoids, Amino acids, and Anthraquinones. The acute toxicity experiments revealed that rats exhibited tolerance to a maximum dose of 2000 mg/kg body weight, and no discernible alterations in behavior were detected across all experimental groups. Hence, fractions equivalent to one-fourth and one-eighth of the maximum tolerated dose of 200 mg/kg body weight were selected for subsequent investigations. Conclusion: In summary, the findings suggest that the application of an ethanolic seed extract derived from Cassia auriculata Linn effectively decreased the progression of urinary stone formation. Additionally, it appears that the efficacy of the treatment impact surpasses that of its preventative counterpart. [ABSTRACT FROM AUTHOR]

This review gives a complete overview of the Cocculus hirsutus (L.) vegetation of Cocculus species (Synonym-Cocculus villosus, Family: Menispermaceae). Numerous phytoconstituents such as alkaloids, phenolic compounds, glycosides, and steroids are present mainly in leaves. Even though the fact that it is frequently used in conventional treatments for conditions including fever, malaria, joint discomfort, and skin conditions as a diuretic, laxative, and antiperiodic. The manufacturing of formulations has only been the subject of a very small number of studies. In the future, a welldeveloped formulation based on topical preparation and in-vivo investigations will be required, coupled with bioassay-guided studies to extract and identify the active ingredients, to demonstrate the formulation with good pharmacological activity of C. hirsutus plants. [ABSTRACT FROM AUTHOR]